Staphylococcus aureus bacteraemia cases in Denmark 2018 Statens Serum Institut Page 3 of 20 This report describes the laboratory and clinical characteristics of the 2,276 cases of Staphylococcus aureus bacteraemia (SAB) in Denmark in 2018. SAB has been surveyed by submission of blood culture isolates since 1957. The Staphylococcus Laboratory at Statens Serum Institut has undertaken strain characterization and collection of clinical and epidemiological information in collaboration with the Danish Departments of Clinical Microbiology (DCM). ACKNOWLEDGEMENT Isolates from SAB cases were received from all DCMs. We are grateful for their voluntary submission. The location of the Danish Departments of Clinical Microbiology. The colors indicate the five regions which provide tax-paid health services to the Danish population.
Materials and Methods

Staphylococcus aureus bacteraemia (SAB) episodes
The Departments of Clinical Microbiology in Denmark referred one S. aureus isolate per bacteraemia episode to the Staphylococcus Laboratory as part of an ongoing collaboration established in 1957. Subsequent isolates from the same patient were only included if the positive blood cultures were drawn at least one month apart (new episode).
Medical information was extracted from The Danish National Patient Register (NPR, Lynge et al. 2011) for each patient with SAB. The Register contains information for all occasions a citizen is in contact with the health care system in Denmark. The following data were extracted: onset of infection in relation to hospital admission, comorbidities and secondary foci (assessed during admission and 3 months after the onset of SAB). Onset of infection was classified as hospital acquired (HA) if S. aureus was found by blood culture more than two days after admission. Comorbidities listed in the Charlson comorbidity index (1987) were extracted based on the ICD-10 codes by Quan et al. (2005) ; for intravenous drug use the definition of Elixhauser et al. (1998) was used. A comorbidity index score was calculated based on the revised weights by Quan et al. (2011) . ICD-10 codes used to identify secondary infections are shown in Appendix 1. Thirty-day all cause case fatality was calculated based on data extracted from the Danish Civil Registration System (DCRS, Pedersen et al. (2006) ). Demographic data was obtained from the homepage of Statistics Denmark (http://www.statistikbanken.dk/bef5).
Typing
PCR detection of the spa gene confirmed the submitted isolates to be S. aureus. The PCR simultaneously detected the spa, mecA, mecC, and lukF/S-pv genes (pvl) (Stegger et al. 2012 ).
The isolates were typed by sequencing of the spa gene. spa types and clonal complexes (CC) were annotated using Bionumerics 6.6 (Applied Maths, Sint-Martens-Latem, Belgium) and Ri-domStaphType 1.4 (Ridom GmbH, Würzburg, Germany). spa types were approximated to multilocus sequence typing (MLST) clonal complexes (CC), using the MLST homepage and eBURST (https://pubmlst.org/saureus/).
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Antimicrobial susceptibility testing
Results
Patient information
In 2018, 2,276 cases of SAB were recorded ( Figure 1) ; of which 2,043 (90%) constituted primary and 233 subsequent episodes. Methicillin-resistant S. aureus (MRSA) was identified from 37 cases (1.6%). The incidence rate of SAB was 39.4/100,000 inhabitants ( Figure 2 ) and of MRSA-SAB 0.64/100,000 inhabitants. The number of new cases has increased by 5% each
year since 2010, also when taken the increasing population into account. There was more males than females (64% males vs. 36% females) among the cases of SAB in 2018. This proportion has been relatively constant comprising 60%-64% during the last 20 years. 
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Age
More than 80% of the SAB patients in 2018 were older than 50 years and 24% were older than 80 years ( Figure 3 ). The Danish population only included 4% older than 80 years in 2018 and the incidence of SAB among people above 80 years of age (245.4/100,000 inhabitants) was seven times higher than for the rest of the population (31.1/100,000 inhabitants). The age distribution of SAB cases shows a trend towards the two oldest age groups. In 2010 41% of the SAB cases were above 70 years of age while in 2018 they constituted 51%. 
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Case fatality
The 30-day all-cause case fatality was 22.4% in 2018 (Table 2) . The rate has been between 17-24% for the last 25 years ( Figure 4 ). Case fatality was low between 1-30 years, increased from the age group of 31-40 years, and patients above 80 years had a case fatality rate of 42.6% (Table 2) , almost twice as high as the average. There was no difference in 30-day allcause case fatality between men and women (22.4% and 22.9%, respectively). 
Acquisition
A total of 542 cases (23.8%) had an onset of infection two or more days after admission to a hospital (HA). The corresponding percentage was 25.8% in 2017 and has been steadily decreasing since 2002 (from 41%). Assignment of acquisition to health-care related cases with a community onset (HACO) and community acquired was not possible with data from NPR. The
HACO category constituted an increasing number throughout the period and an increasing part of the cases up until 2009.
Secondary infections
254 cases (11.2%) had a secondary infection registered during admission and within three months, the number was 594 cases, corresponding to 26.1%. Endocarditis was the most prevalent secondary infection, followed by prosthetic infection, spondylitis, and arthritis (Table 3) .
Myositis, abdominal abscesses and tenosynovitis were all registered in less than 1%. No major changes of secondary infections in the period 2013 to 2018 have been observed; however CNS shows a decreasing trend (Table 4) . had no comorbidities registered, while 874 cases (38%) had a comorbidity index score of 1-2, and 697 cases (31%) had a score of more than 2. 
Typing
spa typing was successful for 2,260 isolates (99.3%). A total of 630 different spa types were identified, and ten spa types accounted for 34% of the isolates (Table 6 ). The same ten spa types were the most prevalent in 2016 and 2017 but with some differences in ranking. A total of 442 spa types (70% of all spa types) were only found once. Putative assignment to MLST CC was possible for 1,940 isolates (85%). In the remaining cases, assignment was not possible due to low number of repeats in the spa type or an otherwise unresolved relationship with MLST typing. A total of 27 MLST CC groups were assigned. The three most prevalent CC (Table 7) . Twenty-nine SAB isolates were pvl positive (1.3%), of which five were MRSA (spa types three t005/CC22, one t008/CC8 and one t044/CC80). The pvl positive isolates were distributed among 25 different spa types and eleven MLST CC groups; six isolates had an unresolved relationship with MLST typing.
CC398
CC398 MRSA isolates have been associated with a reservoir in livestock. CC398 constituted 51 SAB cases (2.2%) in 2018 of which 8 were MRSA. Seventeen belonged to spa type t571, thirteen to spa type t034, twelve to t1451 and the remaining belonged to seven other spa types. Table 8 shows the prevalence of resistance to the antimicrobials tested. The resistance profiles are shown in Figure 5 . Figure 6 shows selected resistance prevalences from 1980 to 2018.
Antimicrobial susceptibility testing
Resistance to penicillin was 72.2% (71.9% in 2017). Resistance to fusidic acid increased to 16.7%, the highest recorded after two years of lower prevalence. All tested SAB isolates were susceptible to ceftaroline, ceftobiprole, linezolid, mupirocin, trimethoprim/sulfametoxazole and vancomycin in 2018. The proportion of isolates susceptible to all antibiotics was 21.4%. The proportion of resistance to at least one antimicrobial in addition to penicillin was 20.4% and the proportion of resistance to at least two and three additional antimicrobials were 6.9% and 2.2%, respectively. 
Conclusions
The number of recorded SAB cases increased in 2018 and the long-term trends demonstrate increasing numbers and incidence. The prevalence of MRSA cases was 1.6%, lower than in the previous two years (both above 2%). Case fatality among MRSA SAB cases (18.9%) was lower but not statistically significant from MSSA SAB cases (22.5%). Almost three quarters of all blood isolates were either fully susceptible or resistant only to penicillin.
More than two-thirds of all patients had at least one comorbidity registered, and three months after onset of SAB, one-fourth of all cases had a registered secondary infection, reflecting that SAB primarily affects patients with a compromised immune status and has severe consequences. 
